TP53 and colorectal carcinoma: The comparison of the overall survival in patients with CRC categorized according to serum p53-Ab positivity (i.e., serum p53-Ab ≥1.3 IU/ml) did not reveal a significant difference (P = 0.952; Figure 6B).